Research Associate - CRISPR/AAV
Date Posted
10 Nov, 2024
Work Location
Salary Offered
$55000 — $70000 yearly
Job Type
Experience Required
1+ years
Remote Work
Not Allowed
Stock Options
No
Vacancies
1 available
Date Posted
10 Nov, 2024
Work Location
Salary Offered
$55000 — $70000 yearly
Job Type
Experience Required
1+ years
Remote Work
Not Allowed
Stock Options
No
Vacancies
1 available
Company Overview
Nephrogen is a VC-backed seed-stage biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no cure or effective treatment. Nephrogen was founded by Demetri Maxim (a PKD patient and scientist from Stanford University), Vivek Bhalla, and George Church. Nephrogen is headquartered at BioLabs at NYULangone, a vibrant state-of-the-art accelerator with over 40 Seed and Series A biotech companies, in the heart of New York City’s SoHo neighborhood.
We are looking for a Research Associate to join our team and contribute to the development and discovery of next-generation gene therapies for kidney diseases. This role offers the opportunity to engage in high-impact translational research within an early-stage, fast-paced startup environment. The ideal candidate will have a BS or MS with prior experience in a biology laboratory environment and possess a strong work ethic, ability to work independently, attention to detail, and capable of juggling several tasks and responsibilities concurrently.
Key Responsibilities
Desired Skills and Experience
Our Scientific Advisory Board includes several field leaders in kidney disease and genetics, including Terry Watnick (NIH PKD Center) and Mark Kay (Stanford University). Our team has spent the last 10 years solving the key bottleneck in the field of getting high efficiency delivery to the kidney. We developed novel AAV capsid variants that target kidney epithelial cells and are combining this technology with CRISPR-Cas genome editing to develop one-time curative treatments for PKD and other genetic kidney diseases. We’re boldly committed to applying our innovative technology towards reimagining kidney disease patient care.
BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.
Home
Jobs
Investors
Members